Breeze Holdings Stock Price, News & Analysis
YDES
NASDAQ
Company Description
Welcome to the overview page for Breeze Holdings (YDES), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
JAN
01
January 1, 2027 - December 31, 2027
Clinical
Exosome ophthalmic trials
Planned exosome-based ophthalmic treatment trials throughout 2027
JAN
01
January 1, 2027 - December 31, 2027
Clinical
Start exosome-based trials
Ophthalmology program to initiate exosome-based treatment trials in 2027
JAN
01
January 1, 2027 - December 31, 2027
Clinical
Clinical trials start
Planned clinical trials for corneal stem-cell and exosome-based eye treatments
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Breeze Holdings (YDES)?
The current stock price of Breeze Holdings (YDES) is $18.505 as of October 14, 2025.
What is the market cap of Breeze Holdings (YDES)?
The market cap of Breeze Holdings (YDES) is approximately 1.3B. Learn more about what market capitalization means .